MBX Biosciences (MBX) PT Raised to $86 at Citizens on 'Good' MBX 4291 Update
Tweet Send to a Friend
Citizens analyst Jonathan Wolleben raised the price target on MBX Biosciences Inc (NASDAQ: MBX) to $86.00 (from $76.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
